Imricor Medical Systems, Inc. · ASX:IMR

Imricor Medical Systems — Shareholder Meeting (May 2020)

16 slides from Imricor Medical Systems's shareholder meeting presentation, May 13, 2020

  1. Slide 1: Welcome to the Imricor Annual Meeting

    For personal use only Welcome to the Wednesday, 13 May 2020 (AEST) Imricor Annual Meeting Tuesday, 12 May 2020 (CDT)

  2. Slide 2: Please submit questions at any time throughout the meeting

    Please submit questions at any time throughout the meeting For personal use only • When the question function is available, the Q&A icon will appear at the top of the app. • To send in a question, simply click in the ‘Ask a question’ box, type your question and the press the send arrow • Your questi

  3. Slide 3: Voting online at the virtual meeting

    Voting online at the virtual meeting For personal use only • When the poll is open, the vote will be accessible by selecting the voting icon at the top of the screen • To vote simply select the direction in which you would like to cast your vote, the selected option will change colour. • There is no

  4. Slide 4: Imricor's Board of Directors

    Imricor’s Board of Directors For personal use only Steve Wedan Mark Tibbles Doris Engibous Peter McGregor President and CEO, Non-executive Director Non-executive Director Non-executive Director and Chair 4 Imricor Annual Meeting 2020

  5. Slide 5: Chair's Address

    Chair’s Address For personal use only 5 Imricor Annual Meeting 2020

  6. Slide 6: Commercial launch – first procedures at Dresden Heart Centre

    Commercial launch – first procedures at Dresden Heart Centre For personal use only Dr. Christopher Piorkowski and Dr. Thomas Gaspar performing initial procedures at the Dresden Heart Centre 6 Imricor Annual Meeting 2020

  7. Slide 7: Active catheter imaging supporting lab adoption

    Active catheter imaging supporting lab adoption For personal use only Vision-MR Ablation Active Catheter Imaging Provides Catheter tip • Fluoroscopic-like MR imaging with easily identified catheter tip • Increased speed for AFL ablations compared to active tracking and mapping • Enhanced speed of ad

  8. Slide 8: Lab roll out plans stalled by COVID-19

    Lab roll out plans stalled by COVID-19 Key lab For personal use only • Dresden: Routine clinical procedures commenced in January operational • Haga: Adv-MR installed 3 Sites with • UMC Ams: Adv-MR installed Signed Contracts • Leipzig: Adv-MR installed 7 Sites with Agreements in • In final stages of

  9. Slide 9: Adapting to COVID-19 – launch of first online educational seminar

    Adapting to COVID-19 – launch of first online educational seminar For personal use only 9 Imricor Annual Meeting 2020

  10. Slide 10: Master purchasing agreement with Sana

    Master purchasing agreement with Sana For personal use only Sana is the largest Group Purchasing Organisation in Germany • 600 cooperating hospitals and medical institutions across Germany and Switzerland • 80 of these sites perform cardiac catheter ablations – potential Imricor customers • Streamli

  11. Slide 11: Product line expansion - improve gross margin, support expanding indications

    Product line expansion - improve gross margin, support expanding indications Steerable Sheath and Diagnostic Catheter Transseptal Needle For personal use only • Prototype phase • Regulatory strategy being developed • Fully staffed execution • Aiming to be ready for clinical trials in 2021 • Developm

  12. Slide 12: A phased approach to geographic expansion

    A phased approach to geographic expansion For personal use only EU Australia US Local agent to be selected in near term. Europe CE mark achieved Detailed approval strategy United States in planning phase. PHASE 1 FDA strategy well The Netherlands, Austria, advanced. Germany and Switzerland. Targetin

  13. Slide 13: Growing the team to deliver growth opportunities and support product roll out

    Growing the team to deliver growth opportunities and support product roll out For personal use only FTEs at IPO FTEs Today G&A G&A Manufacturing 2 5 4 Manufacturing 11 Sales & Marketing 1 Total 25 Total 43 Sales & Marketing Reg & Quality R&D 5 3 R&D 18 14 Reg & Quality 5 13 Imricor Annual Meeting 20

  14. Slide 14: Imricor's Board of Directors

    Imricor’s Board of Directors For personal use only Steve Wedan Mark Tibbles Doris Engibous Peter McGregor President and CEO, Non-executive Director Non-executive Director Non-executive Director and Chair 14 Imricor Annual Meeting 2020

  15. Slide 15: Thank you for your support

    Thank you for your support For personal use only 15 Imricor Annual Meeting 2020

  16. Slide 16: Disclaimer

    Disclaimer The material contained in this presentation is intended to be general background information on Imricor Medical Systems Inc (“Imricor”) and its activities. For personal use only The information is supplied in summary form and is therefore not necessarily complete. It is not intended that

Imricor Medical Systems — Shareholder Meeting (May 2020) on 6ix